Skip to main content
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited — Investor Relations & Filings

Ticker · ONESOURCE ISIN · INE013P01021 LEI · 335800TP5C932B9IQT98 BSE.NS Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2026-04-17 Regulatory Filings
Country IN India
Listing BSE.NS ONESOURCE

About Onesource Specialty Pharma Limited

https://www.onesourcecdmo.com/

Onesource Specialty Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) providing integrated solutions for complex pharmaceutical products. The company focuses on the development and large-scale manufacturing of specialty injectables, softgel capsules, and complex formulations. Its service portfolio encompasses the entire product lifecycle, including formulation development, clinical trial supply, and commercial-stage production. Onesource operates advanced manufacturing facilities designed to meet global regulatory standards, catering to diverse therapeutic areas. By leveraging technical expertise in sterile products and differentiated dosage forms, the organization supports global pharmaceutical partners in bringing high-entry-barrier medicines to market. The platform is built on a foundation of quality compliance and operational excellence to ensure the delivery of critical healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short notification letter addressed to stock exchanges about the renewal of the EU-GMP certification for a manufacturing facility. It is an announcement of a regulatory compliance event rather than a financial report, management change, or shareholder meeting material. The document length is only 1572 characters, and it does not contain financial data, audit information, or detailed report content. It is not a report itself but an intimation to the exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-17 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notification letter addressed to stock exchanges regarding the ESG rating assigned to the company by an external agency for the financial year FY25. It references compliance with SEBI Listing Regulations and a SEBI Master Circular. The document does not contain any financial statements, detailed ESG report, or comprehensive analysis. It is an announcement of an ESG rating received, not the ESG report itself. The document length is only 2028 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Environmental & Social Information (SR) as it relates to ESG rating information, but since it is only an intimation and not a full ESG report, and given the short length and nature of the document, the fallback category Regulatory Filings (RNS) is more appropriate as it is a regulatory announcement about ESG rating under SEBI regulations.
2026-04-16 English
General Updates
Share Issue/Capital Change Classification · 100% confidence The document is an official communication dated April 09, 2026, from OneSource Specialty Pharma Limited to stock exchanges BSE and NSE. It announces the allotment of equity shares under the company's Employee Stock Option Plan 2021 (ESOP 2021). The document details the number of shares allotted, the increase in paid-up share capital, and compliance with SEBI regulations. It includes specifics such as share certificate numbers, ISIN, exercise price, and premium per share. This is a clear announcement of a share allotment event related to employee stock options, which affects the company's capital structure. It is not a full financial report, earnings release, or management discussion. It is not a proxy, voting result, or AGM material. The content fits the category of a Share Issue/Capital Change announcement, as it informs about new shares issued and changes in share capital due to ESOP exercise.
2026-04-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India Ltd) informing about the closure of the trading window pursuant to insider trading regulations. It mentions the trading window closure period related to the upcoming declaration of financial results for the quarter and year ended March 31, 2026. There is no actual financial data, report, or detailed financial analysis included. The document is an announcement related to trading restrictions ahead of financial results, not the financial results themselves or a report. It is a regulatory compliance notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-25 English
General Updates
M&A Activity Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a Composite Scheme of Arrangement and Amalgamation (merger by absorption) involving multiple companies. It mentions the Board of Directors' decision to review the next steps before filing an application with the National Company Law Tribunal (NCLT). The document is an announcement about the merger process and related approvals, not the merger filing itself or detailed merger documents. It is not a full merger filing (MA) or tender offer, nor is it a proxy or voting result. The document is also short (2437 characters) and serves as an update on the merger process. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2026-03-06 English
Credit Rating- Others
Regulatory Filings
2026-03-05 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.